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for clinical charactenstics (CO), r2 = 0.22 for CC + complications (COMP) 
and, r2 = 0.72 for CC + COMP + LOS; for PTCA r2 = 0,19 for CC, r2 = 0.49 
for CC + COMP and r2 = 066 lot CC + COMP + LOS, Iho sum el hosp¢ta| 
and total professional cost provide the best cost estvmato currently possible 
Whale cost is declining these data reveal still unexpiavnod variahon ~n cost 
~ D o  PTCA Mortality Outcomes Need to Be 
Rlsk-adluated? Results From the National 
Cilrdlovas©ular Network (NCN) 
ED. Petefson, D, Moore, LH  Muh!baier, ER  OeLong Duke Univ~r~i~: 
Durham. NC, USA 
BacAgreund: Increasing=y, hospitals' percufaneous, COrOnary infenrention 
(PTCA) me,rarity rotes are being compar~ aa ~t marker of quality. These 
comparisons, however, rarely adlust for differences in hospitals" casemix, 
Methods. Using. the NCN ~'~fobaso (n = 58,;'14 PTCA I~rformed at 19 
U,S, centora from 1/94 to 1/977, we compared hospitals' unadlusfed mortality 
ra+lkleg5 with those a~er n~k-ndtusfing the outcomes Ior t2 c/!nica! nsk factors 
(model C.inde~ = 0.815) 
Results: Overall NCN PTCA in-hosp+t~l mortahty rate was t 2%, varying 
from 0,5% tO 24% between hospitals. Below, we display the 19 hospitals 
ranked by their unadjusted and nsk-adl~sted mortality rates. 
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Hospitals' Rlsk-Ad|ustnd Morlallty Rank 
Hospital ranking shifted an average of 3.6 ranks (range 0--117 Spearman's 
coefficient between rankings was modest, 0.63. 
Cor~us~on. Sigeit~cant differences exist between a hospital's unadjusled 
and risk-adjusted PTCA mortality rankings. Thus, compansons of quality 
need to be based on ask-adjusted outcomes in order to be meaningful 
• Increasing Age Adds to the Costs of PTCA 
P.T. Vaitkus. Universd), Hospitals and Case Western Reserve University+ 
Clevelanct OH. USA 
Background. It has been recognized that elderly patients face increased 
ask of perculaneous coronary revasculanzation. We sought to determine d 
increasing age also impacts on the costs of PTCA. 
Methods: We examined cost data on 484 consecutdve PTCA pts over 6 
months. Raw cost data and risk-adlusted cost data were compared for pts 
aged T 70 vs. p~ . 70 
Results: Multivariate analysis identifiedthat PTCA for staole angina was 
associated with lower costs, whereas PTCA for acute MI, shock, and the 
number of lesions dilated were associated with increasing costs; these vari- 
ables were used to perform ask adjustment. Older pts were more likely to be 
female (53% vs 31%, p - 00001) and had more diseased coronaries (1.8 
vs 1.56, p = 0009) than young pts There were no differences in # of les~ons 
dilated, indication for PTCA, complication rates, clinical urgency, need for 
antecedent bepann or iv nitroglycerin, frequency el new .tevice usage, or 
AHA,'ACC lesion complexity. Costs for older pts ($9763".g8 .~: 7881.897 were 
significantly higher than for young p!s ($8341.78 .~ 5879.11; g = 0.036). A 
significant difference persisted after adlustment for baseline variables. Older 
pts had longer overall and post-PTCA lengths of stay (LOS). The trend for a 
longer pre-PTCA LOS for older pts did not reach stahstcial significance. 
Conclusion: Older pts have longer LOS and costs of PTCA. Efficienctes 
achieved tn at-large PTCA populations may not be transferrable to older pts. 
As current policies do not provide for increasing reimbursement for older 
patients, the aging of the population will translate into increased cost and 
falling profit margins for providers of PTCA services 
• Internal Validity of AMI Databases: A Comparison 
" -  of the NRMI-2 and CCP Databases 
NR Every, P Frederick, M Robinson C Maynard, L Bowlby, HV Barren 
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For patients with AMI, there ~m two large (~ffibaso~ which attempt to c~l~ 
tore pf characteriStiCs, freatnl~nt~ and outcomes, The Natiooa! Registry 0t 
Myocardial Infamtion (NRMb;~) is a voluntary indusfn/~poosored Roe, airy 
that folios on IocPI hespffa! pt identification aed chart abstraction while 
HCFA's Cooperative Cardiovascular Proje~t (CCP) is a govemment.spoo. 
soled database with centralized ca~o ascerlainmenf and validated chaff 
abstraction pr~e~,  In orOer to compare the two d~tabases, we ~lectecl 
Medicare.eligible pts from each database admitted to the same ho.~pitals 
during the same time pmiod in 1,087 hospitals (35,675 pta tn NRMb2 and 
42,703 pts in CCP), We then compared the two cohorts 
CCP (N ~ 42,703i NFIMI,2 (N, 35.875| P value 
Age (mean ~ SD) ?73 ;6 9 O 3r~t 
Gem'lef (% Mafel 494 503 O 0r.5 
White RaCe (%l 89 5 866 0001 
USe el '~r= |%) 14 8 15 6 0 e0t 
Cath (%) 32 B 33 3 0 156 
PTCA (%) 12.5 12 8 0 640 
CABG (%) ? 0 7 1 0420 
Hospital Monahty (%) 16 1 t97 O 001 
We then matched mdiwdual pts, and were able to identily 25,684 pt 
matches from each dataset In this pt-level comparison there was agreement 
in vanable classification m race 96%, gender I00%, age 99%, pnor AM188%, 
use of TTx 98%. cath 98%. and hospital mortality 99.4%. 
We conclude, that despite possible non..consecutNe case ascertainment, 
the hospital-based NRMI-2 compares favorably to the more centralized CCP 
database 
• Relationship of Clinical Variables to Hospital Cost 
for Coronary Interventions: A Unlvarlate and 
Multivariate Analysis 
RW Ltgon, F L. Mike,, JT  Dove, CL  Lucore Prame Cardiovascular 
Consultants, Ltd., Spnnglretd, I/heels. USA 
To determine the relationship of clinical vanables to hospital cost, we reviewed 
data on 2399 consecutwe hospktat discharges between 1/96 and 6~7 after 
coronary inlen~entions (DR'3 112) Baseline characlenstics el tl~e group 
included: age of 64.7 ~, 12.0 years. 64% males, 4.7% acute MI, 67%, stents. 
The ave.age hospital cost was $9499 and lenolh ot stay was 3.2 days 
Multiple stepwvse regression was used to develop a regresmon equatvon for 
predicting hospital cost (R;: = 050: p - 00017 
t,,,~an Hospffal Cos15 IUnlvarlato] Regression 
With iS) Without (St P ($1 Coeff+oenl ($l 
Acute M1 r 0680 944 l 
D~abetas 9962 9361 
MI 3a dny~, 10661 9126 
Muitlves~et CAO 10830 9049 
A~ • 70 9774 9341 
F~rn~te 9722 9372 
Stenr Procedure 10689 7116 
LVEF- 40°° 9499 9336 
Hx et CHF t1383. 9294 
Prior Inter~enhon 653~ 9879 
Abclxtmab use ~ q6;:50 8764 
2 no Iriterventron 1614,3 9290 
Co51 per each stem 
0 003 173R 68 
9004 46950 
o 001 1357 63 
0 oo I 548 52 
0018 498 66 
0 057 43914 
0001 202802 
0001 41707 
0001 182137 
0 001 42068 
ooor 118801 
0 001 647082 
1332 
Predicted cost = regression constant ($5243.43) z: appidcable regres+ 
sien coefficients. Thus. selected chnical vanables can be used to pn~dicl a 
significant proportion of the costs of hospvtalizatien for coronary intervention 
